TMC-2004

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTMC-2004
Drug Alias Namerenal disorder therapy (Targeted Molecules)ghrelin homolog (Targeted Molecules)TMC-2004
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGrowth hormone receptor modulatorsGhrelin/growth hormone secretagogue receptor agonists
TargetsGrowth hormone receptorGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTargeted Molecules Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargeted Molecules Corp
Active IndicationsN/A
Inactive IndicationsKidney Diseases

Other Information

ATC CodeN/A
Related LinksN/A